Clinical Trials Directory

Trials / Completed

CompletedNCT06360510

Comparison of %5 Dextrose and Betamethasone Injections in Patients With Carpal Tunnel Syndrome

Comparison of the Effectiveness of Ultrasound-guided 5% Dextrose and Betamethasone Injections in Patients With Carpal Tunnel Syndrome.

Status
Completed
Phase
Study type
Observational
Enrollment
30 (actual)
Sponsor
Gaziler Physical Medicine and Rehabilitation Education and Research Hospital · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The aim of the study is to compare the effectiveness of ultrasound-guided betamethasone and 5% dextrose injection, which is routinely applied in clinical practice, in patients with mild and moderate carpal tunnel syndrome (CTS).

Detailed description

It is planned as an observational, single-center clinical study.A total of 28 patients diagnosed with mild-moderate carpal tunnel syndrome who meet the inclusion criteria will be included in the study.Patients who had been experiencing trigger finger symptoms for at least three month and who presented to the Gaziler Physical Medicine and Rehabilitation Training and Research Hospital, affiliated with the Health Sciences University Faculty of Medicine. Patients will be divided into two groups. One group will receive 5% dextrose, the other group will receive 1 session of local injection by mixing Celeston chronodose \[1ml/3 mg betamethasone acetate+3,947 mg betamethasone disodium phosphate (equivalent to 3 mg betamethasone)\] and 1 ml 2% prilocaine. Evaluations will be made before injection, at weeks 4 and 12.

Conditions

Interventions

TypeNameDescription
PROCEDURE%5 dextrose injectionhydrodissection with %5 dextrose
PROCEDUREbetamethasone injectionperineural betamethasone injection

Timeline

Start date
2023-05-05
Primary completion
2024-05-05
Completion
2024-05-05
First posted
2024-04-11
Last updated
2026-02-23

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT06360510. Inclusion in this directory is not an endorsement.